Home health-care provider Amedisys Inc. March 30 asked the U.S. Supreme Court to take up a federal appeals court ruling reviving shareholder claims that the entity and certain key officials improperly inflated Medicare reimbursements (Pub. Emps. Ret. Sys. Miss. v. Amedisys Inc., U.S., 14-1200, 3/30/15).
Specifically, the defendants asked the justices to resolve a circuit split over the pleading of loss causation.
“Insisting on particularity,” they urged, “would guard against misuse of the securities laws to recover for losses caused by `other factors,’ not by an alleged fraud.”
Partial Disclosures.
In their lawsuit, the plaintiffs contended that ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.